Drug Shows Promise for FSGS

Sparsentan, a novel dual-action drug, shows promise for the treatment of focal segmental glomerulosclerosis (FSGS), a kidney disease for which no FDA-approved pharmacotherapy exists, researchers reported at the American Society of Nephrology's 2016 Kidney Week meeting.

Alpha Blockers Aid Ureteric Stone Passage

Medical expulsive therapy with alpha blockers can promote clearance of ureteric stones 5 mm and larger, a new systematic review and meta-analysis confirms.

Handling Negative Doctor Reviews

Managing complaints can be a way to make or break your patient relationships and online reputation.

Sodium Reduction May Improve Albuminuria

A reduced sodium diet may improve residual albuminuria in chronic kidney disease (CKD) patients free of diabetes who are treated with a single renin-angiotensin-aldosterone system (RAAS) inhibitor.

Prostate Cancer Risk Lower With HIV

HIV-infected men on antiretroviral therapy have a lower incidence of prostate cancer (PCa) compared with those in the general population, new study findings suggest.

Kidney Week 2016 Conference

Get a sneak peek of happenings at the American Society of Nephrology's Kidney Week 2016.

Partial Nephrectomy OK for Seniors

Partial nephrectomy (PN) and radical nephrectomy (RN) are associated with similar survival outcomes among elderly patients, a new study suggests.

HIPAA: Storing Info on the Cloud

Practices benefit from cost savings and easy access to patient records, but information breaches are still possible.

Hyperkalemia Boxed Warning Removed

The FDA has approved removal of a boxed warning from the patiromer (Veltassa) drug label related to the timing of drug administration.

Omega-3s May Explain HD Obesity Paradox

Omega-3 fatty acids may explain the obesity paradox observed in patients with advanced chronic kidney disease (CKD), according to study findings presented at the American Society of Nephrology's 2016 Kidney Week meeting.

CME: SGLT-2 Inhibitors for Type 2 ...

Increased clinical research has been focused on the sodium-glucose co-transporter 2 (SGLT-2) inhibitors for the management of type 2 diabetes.

Looking for a Job?

Access our job board to view over 1,000 job openings throughout the US.

RUN Social Media Survey

Tell us about your social media habits for a chance to win a free gift card.

Departments

Sign Up for Free e-newsletters